Volume 15, Number 9—September 2009
Research
Susceptibilities of Nonhuman Primates to Chronic Wasting Disease
Table 3
No. monkeys | CWD inoculum | Route of inoculation | Titer inoculated† | Current mpi |
---|---|---|---|---|
1 (no. 609)‡ | MD-1 | Intracerebral | 2.5 × 106 | NA |
1 | MD-1 | Intracerebral | 2.5 × 106 | 70 |
3 | MD-1 | Oral | 2.0 × 109 | 70 |
2 | Elk-1 | Intracerebral | 3.2 × 105 | 70 |
3 | Elk-1 | Oral | 2.5 × 108 | 70 |
2 | WTD-1 | Intracerebral | 1.0 × 106 | 70 |
3 | WTD-1 | Oral | 1.2 × 109 | 70 |
*CWD, chronic wasting disease; mpi, months postinfection; NA, not available.
†Infectivity titers were determined by using endpoint dilution titer in transgenic deer expressing mouse prion protein and are listed as the total 50% infectious dose/g of brain.
‡Monkey 609 was euthanized at 48 mpi, and no protease-resistant prion protein was detected by Western blot or immunohistochemical analysis.
Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.